Rezolute (RZLT) Gains from Investment Securities (2017 - 2026)
Rezolute recorded quarterly Gains from Investment Securities of $2.2 million in Q1 2026, down 69.04% quarter-over-quarter from $7.1 million in Q4 2025, and down 82.58% year-over-year from $12.6 million in Q1 2025.
Rezolute's Gains from Investment Securities history runs 10 years deep, the most recent figure standing at $2.2 million for Q1 2026.
- In Q1 2026, Gains from Investment Securities fell 82.58% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $2.2 million (down 82.58% YoY), while the FY2025 annual figure was $13.0 million, up 393.2% from the prior year.
- Gains from Investment Securities came in at $2.2 million for Q1 2026 at Rezolute, down from $7.1 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $12.6 million in Q1 2025 to a low of $2000.0 in Q3 2024.
- A 5-year average of $5.0 million and a median of $2.5 million in 2024 frame the typical range for Gains from Investment Securities.
- Across the five-year window, Gains from Investment Securities tumbled 99.98% in 2024 and jumped 49153.8% in 2025, its largest moves.
- Rezolute's Gains from Investment Securities stood at $8.5 million in 2022, then sank by 76.15% to $2.0 million in 2023, then surged by 441.05% to $11.0 million in 2024, then plunged by 35.2% to $7.1 million in 2025, then plunged by 69.04% to $2.2 million in 2026.
- According to Business Quant data, Gains from Investment Securities over the past three periods registered $2.2 million, $7.1 million, and $985076.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Rezolute | 374.41 Mn | 374.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.20 Mn |
| Mar 31, 2026 | 2.20 Mn |
| Dec 31, 2025 | 7.11 Mn |
| Dec 31, 2025 | 7.11 Mn |
| Sep 30, 2025 | 985,076.00 |
| Sep 30, 2025 | 985,076.00 |
| Jun 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 400,000.00 |
| Mar 31, 2025 | 12.63 Mn |
| Mar 31, 2025 | 12.63 Mn |
| Dec 31, 2024 | 10.97 Mn |
| Dec 31, 2024 | 10.97 Mn |
| Sep 30, 2024 | 2,000.00 |
| Sep 30, 2024 | 2,000.00 |
| Mar 31, 2024 | 2.48 Mn |
| Mar 31, 2024 | 2.48 Mn |
| Dec 31, 2023 | 2.03 Mn |
| Dec 31, 2023 | 2.03 Mn |
| Sep 30, 2023 | 9.11 Mn |
| Sep 30, 2023 | 9.11 Mn |
| Mar 31, 2023 | 668,000.00 |
| Mar 31, 2023 | 668,000.00 |
| Dec 31, 2022 | 8.50 Mn |
| Dec 31, 2022 | 8.50 Mn |
| Sep 30, 2022 | 8.48 Mn |
| Sep 30, 2022 | 8.48 Mn |
| Jun 30, 2022 | 8.51 Mn |
| Jun 30, 2022 | 8.51 Mn |
| Mar 31, 2022 | 1.59 Mn |
| Mar 31, 2022 | 1.59 Mn |
| Dec 31, 2021 | 1.31 Mn |
| Dec 31, 2021 | 1.31 Mn |
| Sep 30, 2021 | 1.33 Mn |
| Sep 30, 2021 | 1.33 Mn |
| Mar 31, 2021 | 77,000.00 |
| Mar 31, 2021 | 77,000.00 |
| Dec 31, 2020 | 43,000.00 |
| Dec 31, 2020 | 43,000.00 |
| Sep 30, 2020 | 3,000.00 |
| Sep 30, 2020 | 3,000.00 |
| Mar 31, 2020 | 48.16 Mn |
| Mar 31, 2020 | 48.16 Mn |
| Dec 31, 2019 | 35.95 Mn |
| Dec 31, 2019 | 35.95 Mn |
| Sep 30, 2019 | 5.61 Mn |
| Sep 30, 2019 | 5.61 Mn |
| Jun 30, 2019 | 24,000.00 |
| Jun 30, 2019 | 24,000.00 |
| Mar 31, 2019 | 11,000.00 |
| Mar 31, 2019 | 11,000.00 |
| Dec 31, 2018 | -46,000.00 |
| Dec 31, 2018 | -46,000.00 |
| Sep 30, 2018 | 5,000.00 |
| Sep 30, 2018 | 5,000.00 |
| Jun 30, 2018 | -663,000.00 |
| Jun 30, 2018 | -663,000.00 |
| Mar 31, 2018 | -535,303.00 |
| Mar 31, 2018 | -535,303.00 |
| Jun 30, 2017 | 21,291.00 |
| Jun 30, 2017 | 21,291.00 |